Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Formula allergy and intolerance

J A Kerner1

  • 1Department of Pediatrics, Stanford University School of Medicine, CA 94305, USA.

Gastroenterology Clinics of North America
|March 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease.

Philosophical transactions of the Royal Society of London. Series B, Biological sciences·1999
Same author

The human N-methyl-D-aspartate receptor 2C subunit: genomic analysis, distribution in human brain, and functional expression.

Journal of neurochemistry·1998
Same author

Simultaneous isotopic and nonisotopic in situ hybridization histochemistry with cRNA probes.

Brain research. Brain research protocols·1998
Same author

Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene.

Proceedings of the National Academy of Sciences of the United States of America·1998
Same author

Expression of N-methyl-D-aspartate receptor subunit mRNAs in the human brain: striatum and globus pallidus.

The Journal of comparative neurology·1998
Same author

Expression of N-methyl-D-aspartate receptor subunit mRNAs in the human brain: hippocampus and cortex.

The Journal of comparative neurology·1998
Same journal

Long-Term Outcomes of Living Liver Donors.

Gastroenterology clinics of North America·2026
Same journal

Perioperative Management of Living Liver Donor Patients.

Gastroenterology clinics of North America·2026
Same journal

Living Donor Liver Transplantation for Colorectal Cancer Liver Metastasis.

Gastroenterology clinics of North America·2026
Same journal

Living Donor Liver Graft in Adult Populations: Donor Selection and Workup.

Gastroenterology clinics of North America·2026
Same journal

Ethical Considerations in Living Donor Liver Transplantation.

Gastroenterology clinics of North America·2026
Same journal

Clinical Follow-Up After Intestinal Transplantation.

Gastroenterology clinics of North America·2026
See all related articles

Infant formula adverse reactions include immunologic allergy/hypersensitivity and nonimmunologic intolerance, often linked to enzyme deficiencies. This review covers clinical presentation, diagnosis, treatment, formula selection, and allergy prevention.

Area of Science:

  • Pediatrics
  • Clinical Nutrition
  • Immunology

Background:

  • Adverse reactions to infant formulas are common, impacting infant health and development.
  • These reactions are broadly categorized into immunologic (allergy/hypersensitivity) and nonimmunologic (intolerance) responses.
  • Formula intolerance can stem from underlying congenital or acquired enzyme deficiencies, such as disaccharidase deficiency, galactosemia, or hereditary fructose intolerance.

Purpose of the Study:

  • To review the clinical presentation, diagnostic approaches, and therapeutic strategies for infant formula allergy and intolerance.
  • To discuss the appropriate selection and use of various infant formulas available for infants with adverse reactions.
  • To outline guidelines for the prevention of allergic diseases in infants.

Main Methods:

Related Experiment Videos

  • Literature review of clinical presentations, diagnostic criteria, and treatment protocols for infant formula reactions.
  • Analysis of the etiological factors contributing to formula intolerance, particularly enzyme deficiencies.
  • Evaluation of current infant formula types and their suitability for specific infant needs.
  • Synthesis of evidence-based guidelines for the prevention of infant allergies.

Main Results:

  • Differentiated between immunologic formula allergy and nonimmunologic formula intolerance based on underlying mechanisms.
  • Identified specific enzyme deficiencies associated with formula intolerance, impacting diagnosis and management.
  • Provided a comprehensive overview of clinical manifestations, diagnostic tools, and treatment options for both reaction types.
  • Discussed the role of specialized infant formulas in managing adverse reactions.

Conclusions:

  • Accurate diagnosis differentiating allergy from intolerance is crucial for effective infant formula management.
  • Understanding underlying enzyme deficiencies aids in managing formula intolerance.
  • Appropriate formula selection and adherence to allergy prevention guidelines are key to optimizing infant health outcomes.